Midi Health vs SkinnyRx
SkinnyRx has an open FDA warning letter dated February 20, 2026. Midi Health has none. Midi Health lists its visit fee, and the medication is billed separately, so it has no all-in monthly price to set against another seller's. SkinnyRx starts at $248 a month for brand-name semaglutide pill.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Midi Health / SkinnyRx
Midi Health
4.9/10
Featured pick (affiliate partner)
SkinnyRx
6.3/10
- Precision Compounding Pharmacytype not stated
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Midi Health pays us nothing. The scores are computed the same way for both and are shown as computed (Midi Health 4.9, SkinnyRx 6.3). How we are paid
What the record shows
- 01
SkinnyRx has an open FDA warning letter dated February 20, 2026. Midi Health has none.
- 02
Midi Health names Precision Compounding Pharmacy. SkinnyRx names no compounding pharmacy in our record.
- 03
Midi Health lists its visit fee, and the medication is billed separately, so it has no all-in monthly price to set against another seller's. SkinnyRx starts at $248 a month for brand-name semaglutide pill.
- 04
Only SkinnyRx lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen.
- 05
Midi Health covers three states SkinnyRx does not.
- 06
Midi Health does not state its cancellation terms; SkinnyRx states you can cancel at any time.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Midi Health
SkinnyRx
$99/mo
first month only; not compared
$99/mo
first month only; not compared
$1,400/mo
$16,800 a year
$1,400/mo
$16,800 a year
$149/mo
first month only; not compared
$199/mo
first month only; not compared
$248/mo
$2,976 a year
$248/mo
$2,976 a year
Read off each seller’s own pages. Midi Health: September 28, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Midi Health
4.9/10- No FDA warning letter on record
- Names its compounding pharmacy
- Publishes no GLP-1 price
The case for SkinnyRx
6.3/10- Sells compounded semaglutide injection and compounded tirzepatide injection, which Midi Health does not price
- States you can cancel at any time
- Open FDA warning letter, February 20, 2026
- Names no compounding pharmacy
Scores
Midi Health 4.9 · SkinnyRx 6.3 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Midi Health vs SkinnyRx: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Luvo Health7.9
From $179/mo
Visit site - Gala8.5
From $179/mo
Visit site - HealthRX8.2
From $165/mo
Visit site
Sellers closest to these two
- Midi Health vs Embody
- Midi Health vs TrimRx
- Midi Health vs Henry Meds
- Midi Health vs Hims
- SkinnyRx vs Found
- SkinnyRx vs ShedRx
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks